Effects of gefitinib on radiation-induced lung injury in mice.

Effects of gefitinib on radiation-induced lung injury in mice. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Effects of gefitinib on radiation-induced lung injury in mice. Abstract Text:

Clinical studies have demonstrated that gefitinib, an epidermal growth factor receptor inhibitor, is an effective treatment for some patients with advanced non-small cell lung cancer and is generally well-tolerated. However, several reports have also suggested that gefitinib is associated with acute lung injury and subsequent fibrosis. One hypothesis is that gefitinib exacerbates lung injury induced by radiation therapy. It is important to confirm the safety of gefitinib in radiotherapy for patients with lung cancer. In this preclinical study we aimed to clarify the effect of gefitinib on thoracic radiotherapy. Six-week-old female C57BL/6 mice were immobilized in a plastic frame, and the thorax was irradiated once with a dose of 12 Gy on day 0. Gefitinib (20, 90 and 200 mg/kg/day) was administered on days 0 to 5 (acute phase) or days 14 to 19 (late phase) postirradiation. Thoracic irradiation induced lung injury and subsequent fibrosis 5 months later. Gefitinib, administered in the acute phase, had no effect on lung fibrosis or collagen levels induced by irradiation. A high dose of gefitinib (200 mg/kg/day) administered during the late phase significantly reduced fibrosis scores and collagen levels. These results suggest that gefitinib does not exacerbate radiation-induced lung injury and fibrosis in this strain of mice. Therefore, thoracic irradiation is unlikely to be a risk factor for lung injury associated with gefitinib treatment.

Effects of gefitinib on radiation-induced lung injury in mice. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Effects of gefitinib on radiation-induced lung injury in mice. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of Nippon Medical School = Nihon Ika Daiga

VOLUME: 75

Page Numbers: 96-105

Journal Abbreviation:

ISSN: 1345-4676

DAY: 13

MONTH: Apr

YEAR: 2008

Effects of gefitinib on radiation-induced lung injury in mice. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100935589

Effects of gefitinib on radiation-induced lung injury in mice. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Effects of gefitinib on radiation-induced lung injury in mice. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Effects of gefitinib on radiation-induced lung injury in mice.

AFFILIATION: Department of Pulmonary Medicine/Infection and Oncology, Graduate School of Medicine, Nippon Medical School, Japan.

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Nippon Med Sch

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Effects of gefitinib on radiation-induced lung injury in mice Related Publications

• A prospective and randomized study for improvement of acute asthma by non-invasive positive pressure ventilation (NPPV).
• Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model.
• Arterial blood lactate is a useful guide to when rehabilitation should be instigated in COPD.
• Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients.
• Breeding system of the annual Cruciferae, Arabidopsis kamchatica subsp. kawasakiana.
• Clinical factors on cavitary and nodular bronchiectatic types in pulmonary mycobacterium avium complex disease.
• Development of a loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia.
• E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib.
• Effects of gefitinib on radiation-induced lung injury in mice.
• Effects of tonsillectomy in children with IgA nephropathy, purpura nephritis, or other chronic glomerulonephritides.
• Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib.
• Inhibitory effects of macrolide antibiotics on exacerbations and hospitalization in chronic obstructive pulmonary disease in Japan: a retrospective multicenter analysis.
• Microbial substitution of Mycobacterium avium-intracellulare to Mycobacterium abscessus during clinical course.
• PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
• Pancytopenia with hemophagocytosis secondary to parvovirus B19 infection in a family with hereditary spherocytosis.
• Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC).
• Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia.
• Serum biomarker of lung carcinogenesis induced by cigarette smoking.
• Tiotropium Ameliorates Symptoms in Patients with Chronic Airway Mucus Hypersecretion which is Resistant to Macrolide Therapy.
• Transbronchial biopsy is clinically useful in classifying patients with interstitial pneumonia associated with polymyositis and dermatomyositis.
• [Clinical usefulness and health-economic benefits of a new sheet-like medical device (SD-101) for the diagnosis of sleep apnea syndrome]
• [Effects of hyperbaric oxygen treatment on healing of maxillary distraction osteogenesis in Beagle dogs]